Management of Elevated Intracranial Pressure

Initial Management Steps

The American Heart Association recommends elevating the head of bed to 30 degrees with the head in midline position to improve jugular venous outflow and lower ICP 4
Ensure adequate sedation and analgesia to prevent agitation-related ICP spikes, as recommended by the European Society of Intensive Care Medicine 1
Maintain normothermia; treat fever aggressively as hyperthermia worsens cerebral edema, according to the American College of Critical Care Medicine 2
Avoid hypoxia and hypercarbia through proper airway management, as suggested by the American Thoracic Society 2

The Brain Trauma Foundation recommends mannitol as the primary osmotic agent for ICP reduction, dosed at 0.25-0.5 g/kg IV over 20 minutes, repeated every 6 hours as needed 3
The Neurocritical Care Society suggests that hypertonic saline (3% or 23.4%) is equally effective to mannitol at equiosmotic doses (~250 mOsm) and is preferred when hypovolemia, hypotension, or hypernatremia are concerns 2, 3, 5

The American College of Cardiology recommends maintaining CPP between 60-70 mmHg by avoiding antihypertensive agents that cause cerebral vasodilation 1, 2
The European Society of Intensive Care Medicine defines CPP as Mean Arterial Pressure - ICP 1

The Brain Trauma Foundation strongly recommends ICP monitoring as part of protocol-driven care for patients at risk of elevated ICP based on clinical and imaging features 1
The Neurocritical Care Society suggests that intraparenchymal monitors or ventricular catheters are most reliable and accurate for ICP monitoring 1

The American Association of Neurological Surgeons recommends external ventricular drainage as most effective for persistent intracranial hypertension when hydrocephalus is present 3
The Congress of Neurological Surgeons suggests that decompressive craniectomy is reserved for refractory ICP despite maximal medical therapy 2, 3

The National Kidney Foundation recommends avoiding mannitol in patients with established anuria or severe renal disease, and switching to hypertonic saline as primary osmotic agent in patients with renal dysfunction 3, 5
The American Association for the Study of Liver Diseases suggests that mannitol can be used in hepatic encephalopathy with elevated ICP, but with close monitoring of fluid and electrolyte balance 3